X @Bloomberg
Bloomberg·2026-08-28 05:11
Cheaper weight-loss drugs were expected to take off in India. But despite GLP-1s costing as little as $14 a month, demand has been slower than expected. From stigma to hesitant doctors, @satvicked explains why price isn’t the only barrier: https://t.co/vBrehac9eG https://t.co/KHwXvmiTVV ...